# PADCEV EJFV

NDC: 51144-030
Generic name: ENFORTUMAB VEDOTIN
Labeler / Manufacturer: SEAGEN INC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20191218

FDA application: BLA761137

## Active ingredients

- ENFORTUMAB VEDOTIN: 30 mg/3mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51144-030"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51144-030
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b5631d3e-4604-4363-8f20-11dfc5a4a8ed